Notice for venetoclax (Abbvie Pty Ltd)
Active ingredients
venetoclax
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Film-coated tablet
Indication
Treatment of patients with Acute Myeloid Leukaemia (AML)
Therapeutic area
Haematology